EPI-DOSE Trademark

Trademark Overview


On Monday, December 23, 2013, a trademark application was filed for EPI-DOSE with the United States Patent and Trademark Office. The USPTO has given the EPI-DOSE trademark a serial number of 86151049. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, December 10, 2014. This trademark is owned by Asepsis Pharmaceuticals Inc.. The EPI-DOSE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of d...
epi-dose

General Information


Serial Number86151049
Word MarkEPI-DOSE
Filing DateMonday, December 23, 2013
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, December 10, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements


Goods and ServicesAnti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes; Vitamin and mineral preparations for medical use
Pseudo MarkEPIC-DOSE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, December 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Trademark Events


Event DateEvent Description
Wednesday, December 10, 2014ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Wednesday, December 10, 2014ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, December 10, 2014OPPOSITION TERMINATED NO. 999999
Wednesday, December 10, 2014OPPOSITION SUSTAINED NO. 999999
Tuesday, September 16, 2014OPPOSITION INSTITUTED NO. 999999
Tuesday, June 10, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 21, 2014EXAMINER'S AMENDMENT ENTERED
Monday, April 21, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 21, 2014EXAMINERS AMENDMENT E-MAILED
Monday, April 21, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 16, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 11, 2014ASSIGNED TO LIE
Thursday, April 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 28, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 28, 2014NON-FINAL ACTION E-MAILED
Friday, March 28, 2014NON-FINAL ACTION WRITTEN
Friday, March 28, 2014ASSIGNED TO EXAMINER
Friday, January 10, 2014NOTICE OF PSEUDO MARK E-MAILED
Thursday, January 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 26, 2013NEW APPLICATION ENTERED IN TRAM